Your browser doesn't support javascript.
loading
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers.
Amin, Hesham M; Morani, Ajaykumar C; Daw, Najat C; Lamhamedi-Cherradi, Salah-Eddine; Subbiah, Vivek; Menegaz, Brian A; Vishwamitra, Deeksha; Eskandari, Ghazaleh; George, Bhawana; Benjamin, Robert S; Patel, Shreyaskumar; Song, Juhee; Lazar, Alexander J; Wang, Wei-Lien; Kurzrock, Razelle; Pappo, Alberto; Anderson, Peter M; Schwartz, Gary K; Araujo, Dejka; Cuglievan, Branko; Ratan, Ravin; McCall, David; Mohiuddin, Sana; Livingston, John A; Molina, Eric R; Naing, Aung; Ludwig, Joseph A.
Affiliation
  • Amin HM; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Morani AC; Department of Nuclear Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Daw NC; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Subbiah V; Department of Investigational Cancer Therapeutics, 7Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Menegaz BA; Baylor College of Medicine, Department of Surgery, Breast Surgical Oncology, Houston, TX 77030, USA.
  • Vishwamitra D; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Eskandari G; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • George B; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Benjamin RS; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Patel S; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Song J; Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Lazar AJ; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wang WL; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Kurzrock R; Center for Personalized Cancer Therapy, University of California San Diego (UCSD) Moores Cancer Center, San Diego, CA 92037, USA.
  • Pappo A; Department of Pathology, St. Jude's Cancer Research Hospital, Memphis, TN 38105, USA.
  • Anderson PM; Department of Pediatric Oncology, Cleveland Clinic, OH 44195, USA.
  • Schwartz GK; Division of Hematology & Oncology, Columbia University Medical Center, New York, NY 10032, USA.
  • Araujo D; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Cuglievan B; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ratan R; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • McCall D; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Mohiuddin S; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Livingston JA; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Molina ER; Baylor College of Medicine, Department of Surgery, Breast Surgical Oncology, Houston, TX 77030, USA.
  • Naing A; Department of Investigational Cancer Therapeutics, 7Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ludwig JA; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cancers (Basel) ; 12(7)2020 Jul 02.
Article in En | MEDLINE | ID: mdl-32630797
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza